FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Trump Scorches 2 SCOTUS Justices by Name: ‘Democrats don’t really need to “PACK THE COURT”‘

Watch: Trump Blasts NFL Over Possible Amazon, Netflix Deal – Says Many Fans ‘Don’t Make Enough Money to Pay’

ActBlue scrutiny fuels new GOP bills to tighten election donation rules

Alabama AG makes Supreme Court play that could deal decisive blow in redistricting war

GOP lawmaker unveils historic move to ‘expunge’ both ‘maliciously false’ impeachments against Trump

Trump says Iran’s latest proposal reneges on giving up enriched material: ‘Are they stupid people?’

Developing: Virginia Dems Plotting Overthrow of Entire State Supreme Court to Save Redistricting Scheme

Two Israeli Soldiers Sentenced to Prison for Desecration of Mary Statue

WHCA dinner gunman pleads not guilty to attempted Trump assassination charges

WHCA Dinner shooting suspect Cole Allen pleads not guilty, judge scoffs at defense’s power play

Footage shows moments before Frontier Airlines jet struck person on Denver airport runway

Democrats consider plan to wipe conservatives off Virginia Supreme Court: Report

Jeff Landry dismisses concerns about 45,000 discarded ballots after suspended primaries: ‘It’s not my fault’

Former Dem gov in hot seat for ‘complete failure’ in ‘INSANE’ early release of thousands of inmates

House Freedom Caucus vows ‘gloves are coming off’ as FISA deadline looms

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”